The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 71, doi. 10.2147/BLCTT.S490021
- By:
- Publication type:
- Article
Works matching IS 11799889 AND DT 2024 AND VI 14
Results: 6
1
2
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 63, doi. 10.2147/BLCTT.S473984
- By:
- Publication type:
- Article
3
Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 49, doi. 10.2147/BLCTT.S468836
- By:
- Publication type:
- Article
4
Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 31, doi. 10.2147/BLCTT.S461529
- By:
- Publication type:
- Article
5
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 1, doi. 10.2147/BLCTT.S407804
- By:
- Publication type:
- Article
6
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 17, doi. 10.2147/BLCTT.S454115
- By:
- Publication type:
- Article